Select a medication above to begin.
Norpace
disopyramide
Black Box Warnings .
Increased Mortality
excessive mortality or nonfatal cardiac arrest rate (7.7% encainide/flecainide vs. 3% placebo) in asymptomatic non-life-threatening ventricular arrhythmias w/ MI 6 days - 2 years prior; restrict use to life-threatening ventricular arrhythmias, no survival benefit in pts w/o life-threatening arrhythmias
Adult Dosing .
Dosage forms: CAP: 100 mg, 150 mg
ventricular arrhythmias
- [<50 kg]
- Dose: 100 mg PO q6h; Start: 200 mg PO x1; 100 mg PO q6-8h if cardiomyopathy or cardiac decompensation; Max: 1600 mg/day
- [>50 kg]
- Dose: 150 mg PO q6h; Start: 300 mg PO x1; 100 mg PO q6-8h if cardiomyopathy or cardiac decompensation; Max: 1600 mg/day; Alt: 200 mg PO q6h if no response/toxicity w/in 6h of loading dose
atrial fibrillation (off-label)
- [100-400 mg PO bid-tid]
- Max: 800 mg/day; Info: for maintenance rhythm control
renal dosing
- [adjust dose amount, frequency]
- CrCl 41-59: 100 mg q6h; CrCl 30-40: 100 mg q8h; CrCl 15-29: 100 mg q12h; CrCl <15: 100 mg q24h; Info: may give loading dose 150 mg x1 if CrCl <41
- HD: 100 mg q24-48h; no supplement after dialysis; PD: 100 mg q24-48h; no supplement
hepatic dosing
- [adjust dose amount]
- hepatic impairment: 100 mg q6h
Peds Dosing .
- Dosage forms: CAP: 100 mg, 150 mg
ventricular arrhythmia (off-label)
- [<1 yo]
- Dose: 10-30 mg/kg/day PO divided q6h; Info: doses may require pharmacy compounding
- [1-4 yo]
- Dose: 10-20 mg/kg/day PO divided q6h; Info: doses may require pharmacy compounding
- [4-12 yo]
- Dose: 10-15 mg/kg/day PO divided q6h; Info: doses may require pharmacy compounding
- [12-18 yo]
- Dose: 6-15 mg/kg/day PO divided q6h; Info: doses may require pharmacy compounding
renal dosing
- [adjust dose frequency]
- CrCl 30-40: give usual dose q8h; CrCl 15-29: give usual dose q12h; CrCl <15: give usual dose q24h
- HD/PD: not defined, consider adult renal dosing for guidance
hepatic dosing
- [adjust dose amount]
- hepatic impairment: decr. usual dose, amount not defined